Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Sharp

Showing results (91-100 of 113) with videos related to

Pageof 12
Sort By:
European Urology|May 1, 2019
Clinical Utility of Circulating Tumour Cell Androgen Receptor Splice Variant-7 Status in Metastatic Castration-resistant Prostate CancerAdam Sharp, Jon C Welti, Maryou B K Lambros, et al.
European Urology|March 24, 2023
Erratum to "B7-H3 as a Therapeutic Target in Advanced Prostate Cancer" [Eur Urol 2023;83(3):224-38]Christina Guo, Ines Figueiredo, Bora Gurel, et al.
The Journal of Clinical Investigation|April 7, 2020
CDCP1 overexpression drives prostate cancer progression and can be targeted in vivoAbdullah Alajati, Mariantonietta D'Ambrosio, Martina Troiani, et al.
Cancer Cell|November 22, 2024
Elucidating acquired PARP inhibitor resistance in advanced prostate cancerGeorge Seed, Nick Beije, Wei Yuan, et al.
Cancer Research|April 6, 2021
JMJD6 Is a Druggable Oxygenase That Regulates AR-V7 Expression in Prostate CancerAlec Paschalis, Jonathan Welti, Antje J Neeb, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2018
Single-Cell Analyses of Prostate Cancer Liquid Biopsies Acquired by ApheresisMaryou B Lambros, George Seed, Semini Sumanasuriya, et al.
Nature Cancer|July 17, 2023
The Akt/mTOR and MNK/eIF4E pathways rewire the prostate cancer translatome to secrete HGF, SPP1 and BGN and recruit suppressive myeloid cellsDaniela Brina, Adele Ponzoni, Martina Troiani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2022
Assessment of Androgen Receptor Splice Variant-7 as a Biomarker of Clinical Response in Castration-Sensitive Prostate CancerAdam G Sowalsky, Ines Figueiredo, Rosina T Lis, et al.
Elife|August 23, 2017
Development of Bag-1L as a therapeutic target in androgen receptor-dependent prostate cancerLaura Cato, Antje Neeb, Adam Sharp, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 27, 2026
Phase I trial of Ipatasertib plus Atezolizumab enhances PI3K/AKT pathway immune responses in solid tumors and refractory glioblastomaCrescens Tiu, Wing Yau, Diogo Silva, et al.
Pageof 12

Showing results (91-100 of 113) with videos related to

Sort By:
Pageof 12
European Urology|May 1, 2019
Clinical Utility of Circulating Tumour Cell Androgen Receptor Splice Variant-7 Status in Metastatic Castration-resistant Prostate CancerAdam Sharp, Jon C Welti, Maryou B K Lambros, et al.
European Urology|March 24, 2023
Erratum to "B7-H3 as a Therapeutic Target in Advanced Prostate Cancer" [Eur Urol 2023;83(3):224-38]Christina Guo, Ines Figueiredo, Bora Gurel, et al.
The Journal of Clinical Investigation|April 7, 2020
CDCP1 overexpression drives prostate cancer progression and can be targeted in vivoAbdullah Alajati, Mariantonietta D'Ambrosio, Martina Troiani, et al.
Cancer Cell|November 22, 2024
Elucidating acquired PARP inhibitor resistance in advanced prostate cancerGeorge Seed, Nick Beije, Wei Yuan, et al.
Cancer Research|April 6, 2021
JMJD6 Is a Druggable Oxygenase That Regulates AR-V7 Expression in Prostate CancerAlec Paschalis, Jonathan Welti, Antje J Neeb, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2018
Single-Cell Analyses of Prostate Cancer Liquid Biopsies Acquired by ApheresisMaryou B Lambros, George Seed, Semini Sumanasuriya, et al.
Nature Cancer|July 17, 2023
The Akt/mTOR and MNK/eIF4E pathways rewire the prostate cancer translatome to secrete HGF, SPP1 and BGN and recruit suppressive myeloid cellsDaniela Brina, Adele Ponzoni, Martina Troiani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2022
Assessment of Androgen Receptor Splice Variant-7 as a Biomarker of Clinical Response in Castration-Sensitive Prostate CancerAdam G Sowalsky, Ines Figueiredo, Rosina T Lis, et al.
Elife|August 23, 2017
Development of Bag-1L as a therapeutic target in androgen receptor-dependent prostate cancerLaura Cato, Antje Neeb, Adam Sharp, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 27, 2026
Phase I trial of Ipatasertib plus Atezolizumab enhances PI3K/AKT pathway immune responses in solid tumors and refractory glioblastomaCrescens Tiu, Wing Yau, Diogo Silva, et al.
Pageof 12